Navigation Links
Shire's New Product Portfolio Delivers Strong Quarterly Performance
Date:10/29/2008

>

operations 12.7 34.7 62.3 (1,663.9)

Loss from discontinued

operations (0.9) - (0.9) -

-------- -------- -------- --------

Numerator for basic and diluted

EPS 11.8 34.7 61.4 (1,663.9)

-------- -------- -------- --------

No. of No. of No. of No. of

Weighted average number of shares shares shares shares

shares: Millions Millions Millions Millions

-------- -------- -------- --------

Basic (1) 540.3 546.4 542.6 538.9

Effect of dilutive shares:

Stock options(2) 1.2 8.2 2.7 -

Warrants(2) - 0.1 - -

-------- -------- -------- --------

Diluted 541.5 554.7 545.3 538.9

-------- -------- -------- --------

(1) Excludes shares purchased by the ESOT and presented by the Company as treasury stock.

(2) Calculated using the treasury stock method.

The share equivalents not included in the above calculation of the diluted
'/>"/>

SOURCE Shire Plc
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Beckman Coulter Signs Agreements with Adventist Health; Broad Product Offering Enhances Delivery of Quality Patient Care
2. PEAK Surgical Introduces PlasmaBlade(TM) Product Line Extensions for Use in General Surgery
3. Lilly Announces Launch of Color Differentiation System for Humalog(R) and Humulin(R) U-100 Insulin Products in the United States
4. GenOdyssee Receives Broad Product Applications Protection in EU for Founding Natural Evolution Technology
5. Consumers Looking to Sustainable Food Production to Feed Global Population
6. Contour Products Introduces Groundbreaking Sleep Apnea, Respiratory and Ergonomic Body Comfort Pillows at Medtrade; Self-Explanatory Products Serve Customer Needs, Expand Retailers DME Offerings
7. Glycotex Reports First Patient Enrollment in Phase IIb Study of Lead Product Candidate GLYC-101 for Wound Healing
8. Sustainable Oils Names Scott Johnson as General Manager, Expands Management Team for Camelina Research and Production
9. Ventria Expands Lactoferrin Production
10. China Biologic Products Provides Preliminary Guidance for 2009 of Revenues of $90 to $100 Million and Net Income of $18 to 22 Million
11. Advanced Analytical Technologies, Inc. Expands Into New Office and Production Space

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...wswire/ -- Myriant Technologies LLC ("Myriant"), a...r of renewable bio-chemicals, Uhde Corporation of...e GmbH, one of the world,s leading engineering con...or the engineering, procurement & construction...based on renewable feedstocks. The execution of t...
(Date:11/6/2009)...-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NA...nnounced updated results from a Phase II study of ...metastatic to the lung in a poster presentation at...y Meeting held in Miami Beach, Florida, from Novem..."A Phase II Study of Intravenous REOLYSIN (Wild-ty...
(Date:11/5/2009)...PRNewswire-FirstCall/ -- GenVec, Inc. (Nasdaq: GN... third quarter ended September 30, 2009. GenVec re...) for the three months ended September 30, 2009 co...are) in the comparable quarter of 2008. For the ni...oss was $14.1 million ($0.15 per share), compared ...
(Date:11/5/2009).... 5 ThermoGenesis Corp. ... products for processing and storing adult stem ce...of fiscal 2010. ,, For the quarter ended Septem...2 million, a 15 percent increase over revenues of ...Company said the key contributors to the growth in...
Breaking Biology Technology:Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8
...ws Accurate Marketing Claims Designed with Input f...ation,s leading livestock,cloning companies announ...management system that will allow food companies t...food processing chain., The program was developed...e last year with all critical participants in the ...
...., Dec. 19 SleepQuest, the leader in,at-home diag...nounced the,launch of an improved version of its m...r to better support its community of,patients, fam... increasing demand for in-home sleep testing and s...ite to meet the needs of our,expanding patient pop...
..., Dec. 19 BioForm Medical,Inc. (Nasdaq: BFRM ) t...Officer, will present a company overview at the up...being held from January 7-10, 2008. BioForm,Medica...y 7th, 2008 at 8:30,a.m. PST (11:30 am EST) at the... live and archived copy of the webcast of BioForm ...
Other Biology Technology:Top U.S. Cloning Companies Announce New System to Track Cloned Livestock 2SleepQuest Launches Updated Web Site 2BioForm Medical to Present at the 2008 JPMorgan Healthcare Conference on January 7, 2008 2
(Date:11/6/2009)...h of the publication of On the Origin of Species, ...S) is publishing open access two peer-reviewed art...ts into evolution. , The two articles are by Kevi..., and James T. Costa of Western Carolina Universit...in," appeared in the October issue of the AIBS jou...
(Date:11/6/2009)...ills, MI-based Law Enforcement Intelligent Devices...and patent-pending Biometric Access Control System...uman Services, National Institutes of Health (NIH)...pport the NIH,s entire police force that is respon... agency. The project is expected to be completed ...
(Date:11/5/2009)... (NABT) will recognize Leonard C. Yannielli, profe...mmunity College (NVCC) in Waterbury, Connecticut, ... NABT annual professional development conference t... , The Evolution Education Award is cosponsored ...(AIBS) and Biological Sciences Curriculum Study (B...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2New artificial enzyme safer for nature 10482 1New artificial enzyme safer for nature 10482 2Now hear this 10478 1Assessing Embryo Metabolism May Aid IVF Success 59948 1Assessing Embryo Metabolism May Aid IVF Success 59948 2
...f a space-age, low-gravity training machine used b...mpacts on muscles and joints by nearly half when s...ir body weight. , The new study has implications ...njuries and for ordinary people returning from kne...sor Rodger Kram of CU-Boulder,s integrative physio...
...resistance on the rise, tuberculosis is emerging a... , But now, innovative research at Weill Cornell ...culosis has an as yet unsuspected weakness -- one.... , "Using novel techniques, we have identified a...nse that M. tuberculosis mounts against the acid...
...ay have found a defense against the Black Plague, ...ation in the Middle Ages and which government agen... Professor Henry Daniell and his team have develop...ffective against the plague. Findings of his Natio...appear in the August edition of Infection and Imm...
Other Biology News:Low-gravity training machine reduces joint, muscle impacts, says CU-Boulder study 2Low-gravity training machine reduces joint, muscle impacts, says CU-Boulder study 3Potential new drug target to fight tuberculosis identified 2Potential new drug target to fight tuberculosis identified 3UCF professor develops vaccine to protect against black plague bioterror attack 2UCF professor develops vaccine to protect against black plague bioterror attack 3
pCDF-1 Expression System plus Competent Cells from Novagen
Chicken Anti-Human Uridine Phosphorylase 1 Polyclonal Antibody, Unconjugated from Abcam
RayBio Mouse AngiogenesisAntibody Array I & 1.1 Service from Raybiotech, Inc.
Goat Anti-Syne-1 (N-19) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Biology Products: